Literature DB >> 16814153

Intensity-modulated radiation therapy for gynecologic cancers: pitfalls, hazards, and cautions to be considered.

Marcus E Randall1, Geoffrey S Ibbott.   

Abstract

Intensity Modulated Radiation Therapy (IMRT) is considered a major advance in radiaton therapy (RT) capability. Therefore, it has been rapidly accepted and implemented in the treatment of multiple cancers in which RT plays a major role. Early reports of IMRT in gynecologic cancers have been largely favorable, particularly in terms of decreased acute morbidity. However, IMRT has not been prospectively shown to be superior to conventional 3-dimensional RT techniques when judged against criteria established in advance. Furthermore, there are many reasons to consider the possibility that outcomes might be compromised by IMRT techniques used to treat gynecologic cancers. This article reviews the potential pitfalls and hazards of IMRT techniques on patient safety and treatment efficacy. In addition, the article describes multiple technical issues with IMRT implementation, arguing for caution in IMRT use.

Entities:  

Mesh:

Year:  2006        PMID: 16814153     DOI: 10.1016/j.semradonc.2006.02.002

Source DB:  PubMed          Journal:  Semin Radiat Oncol        ISSN: 1053-4296            Impact factor:   5.934


  12 in total

1.  Long-term follow-up results of simultaneous integrated or late course accelerated boost with external beam radiotherapy to vaginal cuff for high risk cervical cancer patients after radical hysterectomy.

Authors:  Xin Wang; Yaqin Zhao; Yali Shen; Pei Shu; Zhiping Li; Sen Bai; Feng Xu
Journal:  BMC Cancer       Date:  2015-04-11       Impact factor: 4.430

Review 2.  Current therapy of patients with endometrial carcinoma. A critical review.

Authors:  S Marnitz; C Köhler
Journal:  Strahlenther Onkol       Date:  2011-12-23       Impact factor: 3.621

Review 3.  Radiation-induced small bowel disease: latest developments and clinical guidance.

Authors:  Rhodri Stacey; John T Green
Journal:  Ther Adv Chronic Dis       Date:  2014-01       Impact factor: 5.091

4.  Helical tomotherapy in cervical cancer patients: simultaneous integrated boost concept: technique and acute toxicity.

Authors:  Simone Marnitz; Carmen Stromberger; Michael Kawgan-Kagan; Waldemar Wlodarczyk; Ulrich Jahn; Achim Schneider; Uwe Ulrich; Volker Budach; Christhardt Köhler
Journal:  Strahlenther Onkol       Date:  2010-09-30       Impact factor: 3.621

5.  Plan comparison of volumetric-modulated arc therapy (RapidArc) and conventional intensity-modulated radiation therapy (IMRT) in anal canal cancer.

Authors:  Sabine Vieillot; David Azria; Claire Lemanski; Carmen Llacer Moscardo; Sophie Gourgou; Jean-Bernard Dubois; Norbert Aillères; Pascal Fenoglietto
Journal:  Radiat Oncol       Date:  2010-10-13       Impact factor: 3.481

6.  Consensus guidelines for delineation of clinical target volume for intensity-modulated pelvic radiotherapy in postoperative treatment of endometrial and cervical cancer.

Authors:  William Small; Loren K Mell; Penny Anderson; Carien Creutzberg; Jennifer De Los Santos; David Gaffney; Anuja Jhingran; Lorraine Portelance; Tracey Schefter; Revathy Iyer; Mahesh Varia; Kathryn Winter; Arno J Mundt
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-11-26       Impact factor: 7.038

7.  Challenges in credentialing institutions and participants in advanced technology multi-institutional clinical trials.

Authors:  Geoffrey S Ibbott; David S Followill; H Andrea Molineu; Jessica R Lowenstein; Paola E Alvarez; Joye E Roll
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008       Impact factor: 7.038

8.  A comparative dosimetric study of cervical cancer patients with para-aortic lymph node metastasis treated with volumetric modulated arc therapy vs. 9-field intensity-modulated radiation therapy.

Authors:  Yaqin Wu; Biqing Zhu; Jingjing Han; Hanzi Xu; Zhen Gong; Yongqin Yang; Jian Huang; Emei Lu
Journal:  Ann Transl Med       Date:  2019-11

9.  Comparison of conformal and intensity modulated radiation therapy techniques for treatment of pelvic tumors. Analysis of acute toxicity.

Authors:  Robson Ferrigno; Adriana Santos; Lidiane C Martins; Eduardo Weltman; Michael J Chen; Roberto Sakuraba; Cleverson P Lopes; José C Cruz
Journal:  Radiat Oncol       Date:  2010-12-14       Impact factor: 3.481

10.  Bilateral kidney preservation by volumetric-modulated arc therapy (RapidArc) compared to conventional radiation therapy (3D-CRT) in pancreatic and bile duct malignancies.

Authors:  Sabine Vieillot; David Azria; Olivier Riou; Carmen Llacer Moscardo; Jean-Bernard Dubois; Norbert Aillères; Pascal Fenoglietto
Journal:  Radiat Oncol       Date:  2011-10-31       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.